Addition of sPD-1 successfully overcome the HSP70 vaccine resistance through enhanced expression of IFN-γ and IL-2 genes in tumor-infiltrating lymphocytes and decreased expression of negative regulatory molecules including IL-10, TGF-b, and foxp3. The gene discussed is HOXD13; the disease is neoplasm.